Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia
Background: Mongolia has a high prevalence of Helicobacter pylori infection and gastric cancer. We conducted a prospective, randomized, single-blind study to evaluate the efficacy of common regimens in Mongolia and to obtain specimens for susceptibility testing.Methods: Empiric treatments: 270 patie...
Saved in:
Main Authors: | Tsogt-Ochir Byambajav (Author), Namdag Bira (Author), Gotov Choijamts (Author), Duger Davaadorj (Author), Boldbaatar Gantuya (Author), Tserenchimed Sarantuya (Author), Gidaagaya Sarantuya (Author), Altangerel Enkhtsetseg (Author), Dungubat Erdenetsogt (Author), Adiyasuren Battulga (Author), Tegshee Tserentogtokh (Author), Takeshi Matsuhisa (Author), Yoshio Yamaoka (Author), Khasag Oyuntsetseg (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease
by: Yoshio Yamaoka
Published: (2008) -
Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019) -
Antibiotic Resistance and Therapy for <i>Helicobacter pylori</i> Infection
by: Stella I. Smith, et al.
Published: (2023) -
The Potential Benefits of Vonoprazan as <i>Helicobacter pylori</i> Infection Therapy
by: Muhammad Miftahussurur, et al.
Published: (2020) -
Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis
by: Masoud Keikha, et al.
Published: (2022)